Evidence map›Paper›PMID 39756820›Full record

Trial reportOpen heart2025

Right ventricular strain impairment due to hypoxia in patients with COPD: a post hoc analysis of two randomised controlled trials.

Helga Preiss, Laura Mayer, Michael Furian, Simon Rafael Schneider, Julian Müller, Stephanie Saxer, Maamed Mademilov, Anna Titz, Anwer Shehab, Lena Reimann and 5 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Open heart, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450968 phase4completednot on this map

Dexamethasone for Prophylaxis of Acute Mountain Sickness in Patients With Chronic Obstructive Pulmonary Disease Travelling to Altitude

TypeinterventionalSponsorUniversity of ZurichRan2015 to 2015Enrolled124ConditionsChronic Obstructive Pulmonary Disease (COPD)ArmsDexamethasone, Placebo
NCT03173508 phase4completednot on this map

Effect of Acetazolamide on Right Ventricular Function at Rest in Patients With Chronic Obstructive Pulmonary Disease at Altitude. A Randomized, Placebo-controlled, Double-blind Parallel Trial

TypeinterventionalSponsorUniversity of ZurichRan2017 to 2018Enrolled110ConditionsChronic Obstructive Pulmonary DiseaseArmsACETAZOLAMIDE oral capsule, Placebo oral capsule
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Helga PreissRespiratory Medicine, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0008-6470-6391
Laura MayerRespiratory Medicine, University Hospital Zurich, Zurich, Switzerland.
Michael FurianRespiratory Medicine, University Hospital Zurich, Zurich, Switzerland.
Simon Rafael SchneiderUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Julian MüllerUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Stephanie SaxerUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Maamed MademilovNational Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyzstan.
Anna TitzUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Anwer ShehabClinic for Cardiology, University of Zurich, Zurich, Switzerland.
Lena ReimannUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Talant SooronbaevNational Center for Cardiology and Internal Medicine, Department of Respiratory Medicine, Bishkek, Kyrgyzstan.
Felix C TannerClinic for Cardiology, University of Zurich, Zurich, Switzerland.
Konrad E BlochUniversity Hospital Zurich, Zurich, Zurich, Switzerland.
Silvia UlrichRespiratory Medicine, University Hospital Zurich, Zurich, Switzerland.
Mona LichtblauRespiratory Medicine, University Hospital Zurich, Zurich, Switzerland Mona.lichtblau@usz.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoxic pulmonary vasoconstriction leads to an increase in pulmonary artery pressure (PAP) and potentially right heart failure in healthy individuals and patients with respiratory diseases. Previous studies in patients with chronic obstructive pulmonary disease (COPD) exposed to hypobaric hypoxia have shown an increase in PAP, while traditional echocardiographic parameters revealed only minimal changes at high altitude. Speckle-tracking-derived analysis is potentially more sensitive to assess right ventricular (RV) function and we used this method to investigate the impact on RV function of patients with COPD ascending to high altitude and compared the results with the traditional echocardiographic parameters.

methodsThis post hoc analysis evaluates echocardiographic RV free wall strain (RVFWS) in patients with COPD GOLD grade 1-3 travelling from 760 m to 3100 m for a 2-day stay. An RVFWS over -20% was considered as an indicator of RV dysfunction.

resultsA total of 54 patients (57% men, mean±SD age 58±9 years, forced expiratory volume in 1 s (FEV

conclusionExposure to hypoxia led to RVFWS impairment in more than one quarter of patients with COPD. Strain analysis is a promising, non-invasive method for evaluating RV dysfunction, even in subclinical cases and might be prognostically relevant in patients with lung diseases. TRIAL REGISTRATION NUMBERS: NCT02450968 and NCT03173508.

Indexed as

HypoxiaPulmonary Disease, Chronic ObstructiveVentricular Dysfunction, RightVentricular Function, RightAgedAltitudeEchocardiographyFemaleForced Expiratory VolumeHeart VentriclesHumansMaleMiddle AgedRandomized Controlled Trials as TopicEchocardiographyHypertension, PulmonaryTranslational Medical Research

Identifiers

PMID39756820
PMCPMC11752043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.